Cybele Microbiome
San Diego, US · Delaware corporation · 1 known investors
Cybele Microbiome studies how skincare ingredients affect the skin microbiome and its postbiotic output, using that knowledge in clinical trials to develop products with better efficacy and fewer side effects. It focuses on the link between ingredients, the microbiome, and human skin health.
Founders & leadership
NS
Nicole ScottinFounder
NM
Nicole M. ScottNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 4 rounds · 2018–2024
▶$252KraisedMar 2024 · 5 investors · BiotechnologyRule 506(b)
▶$252KraisedMar 2024 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicole M. ScottExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $252K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$877raisedFeb 2023 · 19 investors · BiotechnologyRule 506(b)
▶$877raisedFeb 2023 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicole M. ScottExecutive Officer, Director
- Offering amount
- $877
- Amount sold
- $877
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedNov 2022 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicole M. ScottExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$893.5KraisedNov 2022 · 19 investors · BiotechnologyRule 506(b)
▶$893.5KraisedNov 2022 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicole M. ScottExecutive Officer, Director
- Offering amount
- $893.5K
- Amount sold
- $893.5K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Cybele Microbiome do?
- Cybele Microbiome studies how skincare ingredients affect the skin microbiome and its postbiotic output, using that knowledge in clinical trials to develop products with better efficacy and fewer side effects. It focuses on the link between ingredients, the microbiome, and human skin health.
- Who founded Cybele Microbiome?
- Cybele Microbiome was founded by Nicole Scott.
- Who are Cybele Microbiome's investors?
- Cybele Microbiome's investors include Evolution VC Partners.
- How much funding has Cybele Microbiome raised?
- Cybele Microbiome has disclosed $1.6M raised across 4 rounds.
- Where is Cybele Microbiome headquartered?
- Cybele Microbiome is headquartered in San Diego, US.